AlzChem Group AG (ALZCF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AlzChem Group AG (ALZCF) with AI Score 47/100 (Weak). AlzChem Group AG develops, produces, and trades chemical products globally, operating through Specialty Chemicals, Basics & Intermediates, and Other & Holding segments. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 16, 2026AlzChem Group AG (ALZCF) Materials & Commodity Exposure
AlzChem Group AG, a global specialty chemicals company, develops and markets a diverse range of products, including dietary supplements, fine chemicals, and industrial solutions. With a focus on calcium carbide chemistry, AlzChem serves multiple sectors across Europe, Asia, and the Americas, maintaining a strong presence in specialty chemical markets.
Investment Thesis
AlzChem Group AG presents a compelling investment case based on its diversified product portfolio, established market position, and exposure to growing end markets. The company's focus on specialty chemicals and dietary supplements provides a degree of resilience against economic cycles. With a P/E ratio of 26.98 and a profit margin of 11.3%, AlzChem demonstrates profitability. Key growth catalysts include expansion in high-margin specialty chemicals and increased demand for its dietary supplement products. However, potential risks include fluctuations in raw material prices and competitive pressures. The company's beta of 0.58 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $1.84 billion reflects investor confidence in AlzChem's market position.
- Profit margin of 11.3% indicates efficient operations and strong pricing power.
- Gross margin of 31.6% demonstrates the value-added nature of AlzChem's specialty chemical products.
- Dividend yield of 1.06% provides a steady income stream for investors.
- Beta of 0.58 suggests lower volatility compared to the overall market, making it a potentially stable investment.
Competitors & Peers
Strengths
- Diversified product portfolio
- Established brands
- Global presence
- Expertise in calcium carbide chemistry
Weaknesses
- Exposure to raw material price fluctuations
- Dependence on specific end markets
- Limited brand recognition compared to larger competitors
- OTC market listing
Catalysts
- Ongoing: Expansion in high-growth markets, particularly in Asia.
- Ongoing: Development and launch of new specialty chemical products.
- Upcoming: Potential strategic acquisitions to expand product portfolio and market reach.
- Ongoing: Increasing demand for dietary supplements and nutritional feed additives.
- Ongoing: Innovation in silicon nitride applications for ceramics, electronics, and solar industries.
Risks
- Potential: Fluctuations in raw material prices could impact profitability.
- Potential: Intense competition in the specialty chemicals industry.
- Potential: Economic downturns could reduce demand for AlzChem's products.
- Potential: Changes in regulations could impact the company's operations.
- Ongoing: Limited liquidity due to OTC market listing.
Growth Opportunities
- Expansion in Dietary Supplements: AlzChem can capitalize on the growing demand for dietary supplements, particularly creatine-based products like Creapure and LIVADUR. The global dietary supplements market is projected to reach $230 billion by 2027, offering significant growth potential. AlzChem's established brands and strong distribution network provide a competitive advantage in this market. Timeline: Ongoing.
- Increased Penetration in Emerging Markets: AlzChem can expand its presence in emerging markets, particularly in Asia, where demand for specialty chemicals and dietary supplements is growing rapidly. The company can leverage its existing infrastructure and partnerships to penetrate these markets. Timeline: Ongoing.
- Development of Sustainable Products: AlzChem can focus on developing sustainable and environmentally friendly products to meet the increasing demand for green chemicals. This includes using renewable raw materials and developing more efficient production processes. Timeline: Ongoing.
- Strategic Acquisitions: AlzChem can pursue strategic acquisitions to expand its product portfolio and market reach. This includes acquiring companies with complementary technologies and products. Timeline: Upcoming.
- Innovation in Silicon Nitride Applications: AlzChem can further innovate in the application of silicon nitride (SILZOT) for ceramics, electronics, and solar applications. The demand for high-performance materials in these industries is growing, offering significant growth opportunities. Timeline: Ongoing.
Opportunities
- Expansion in emerging markets
- Development of sustainable products
- Strategic acquisitions
- Innovation in silicon nitride applications
Threats
- Intense competition
- Economic downturns
- Changes in regulations
- Technological disruptions
Competitive Advantages
- Specialized Expertise: AlzChem has deep expertise in calcium carbide chemistry and related technologies.
- Established Brands: The company has well-known brands like Creapure and DYHARD.
- Diversified Product Portfolio: AlzChem offers a wide range of products for various industries.
- Global Presence: The company has a significant presence in Europe, Asia, and the NAFTA region.
About ALZCF
Founded in 1908 and headquartered in Trostberg, Germany, AlzChem Group AG has evolved into a global specialty chemicals company. Initially focused on calcium carbide chemistry, the company has expanded its product portfolio to include a wide array of specialty chemicals, dietary supplements, and solutions for various industrial applications. AlzChem operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. Its Specialty Chemicals segment offers products like Creapure and Alipure dietary supplements, Creamino nutritional feed additives, LIVADUR creatine supplements, Bioselect products for pharmaceuticals, DYHARD curing agents, and SILZOT silicon nitride. The Basics & Intermediates segment focuses on products based on calcium carbide, calcium cyanamide, and related compounds. AlzChem's products are used in diverse industries, including nutrition, pharmaceuticals, agriculture, and metallurgy. The company has a significant presence in Europe, Asia, and the NAFTA region, serving customers worldwide. AlzChem continues to innovate and expand its product offerings to meet the evolving needs of its global customer base.
What They Do
- Develops and produces specialty chemical products.
- Offers dietary supplements under the Creapure, Alipure, and LIVADUR brands.
- Provides nutritional feed additives under the Creamino brand.
- Manufactures products for pharmaceuticals under the Bioselect brand.
- Produces curing agents for adhesives, coatings, and composites under the DYHARD name.
- Offers silicon nitride for ceramics, electronics, and solar applications under the SILZOT brand.
- Provides products for hot metal desulfurization and secondary metallurgy.
- Offers plant growth regulators and protection additives.
Business Model
- Manufactures and sells specialty chemicals, dietary supplements, and industrial products.
- Operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding.
- Generates revenue from sales to various industries, including nutrition, pharmaceuticals, agriculture, and metallurgy.
- Provides chemical park operations and administrative services.
Industry Context
AlzChem Group AG operates in the specialty chemicals industry, which is characterized by high value-added products and customized solutions. The industry is driven by innovation, sustainability, and increasing demand from various end markets, including nutrition, pharmaceuticals, and agriculture. The competitive landscape includes companies like BRRDF (BASF), DENKF (Evonik), ELKEF (Ems-Chemie), IRLCF (Linde), and KANKF (Kaneka), each with its own strengths and market focus. AlzChem differentiates itself through its expertise in calcium carbide chemistry and its diverse product portfolio. The specialty chemicals market is expected to grow steadily, driven by increasing demand for customized solutions and sustainable products.
Key Customers
- Nutrition and dietary supplement companies.
- Pharmaceutical manufacturers.
- Agricultural businesses.
- Metallurgy and steel industries.
- Electronics and solar energy companies.
Financials
Chart & Info
AlzChem Group AG (ALZCF) stock price: Price data unavailable
Latest News
No recent news available for ALZCF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALZCF.
Price Targets
Wall Street price target analysis for ALZCF.
MoonshotScore
What does this score mean?
The MoonshotScore rates ALZCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andreas Niedermaier
Unknown
Information on Andreas Niedermaier's background is not available in the provided data. Further research would be needed to provide a comprehensive bio, including his career history, education, and previous roles.
Track Record: Information on Andreas Niedermaier's track record is not available in the provided data. Further research would be needed to assess his key achievements, strategic decisions, and company milestones under his leadership.
ALZCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that AlzChem Group AG may not meet the listing requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with limited operating history, penny stocks, and those facing financial difficulties. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Lower liquidity and higher volatility
- Potential for fraud or manipulation
- Less regulatory oversight
- Information asymmetry
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Review any available analyst reports or independent research.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established operating history (founded in 1908)
- Global presence and diverse product portfolio
- Positive financial metrics (profit margin, gross margin)
- Presence in multiple geographic regions
- Employee count of 1541 suggests substantial operations
Common Questions About ALZCF
What does AlzChem Group AG do?
AlzChem Group AG is a global specialty chemicals company that develops, produces, and trades chemical products. The company operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. Its product portfolio includes dietary supplements, fine chemicals, and industrial solutions. AlzChem serves various industries, including nutrition, pharmaceuticals, agriculture, and metallurgy, with a strong presence in Europe, Asia, and the NAFTA region. The company's expertise in calcium carbide chemistry and its diversified product offerings differentiate it from competitors.
What do analysts say about ALZCF stock?
AI analysis is currently pending for ALZCF. Typically, analysts would consider factors such as revenue growth, profit margins, and market share when evaluating the company. Key valuation metrics like P/E ratio and dividend yield would also be assessed. Growth considerations would include expansion in emerging markets, development of new products, and potential acquisitions. Investors should consult multiple sources of information and conduct their own due diligence before making any investment decisions.
What are the main risks for ALZCF?
The main risks for AlzChem Group AG include fluctuations in raw material prices, intense competition in the specialty chemicals industry, and economic downturns that could reduce demand for its products. Changes in regulations could also impact the company's operations. As an OTC-listed stock, ALZCF faces additional risks related to limited liquidity, lower financial disclosure, and less regulatory oversight. Investors should carefully consider these risks before investing in ALZCF.
What are the key factors to evaluate for ALZCF?
AlzChem Group AG (ALZCF) currently holds an AI score of 47/100, indicating low score. Key strength: Diversified product portfolio. Primary risk to monitor: Potential: Fluctuations in raw material prices could impact profitability.. This is not financial advice.
How frequently does ALZCF data refresh on this page?
ALZCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ALZCF's recent stock price performance?
Recent price movement in AlzChem Group AG (ALZCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ALZCF overvalued or undervalued right now?
Determining whether AlzChem Group AG (ALZCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ALZCF?
Before investing in AlzChem Group AG (ALZCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- AI analysis is pending and may provide additional insights.